Compared to luminal breast cancer subtypes, ZEB1 is highly expressed in triple-negative breast cancers, which express neither ERα nor progesterone receptor (PR), which is encoded by an ERα target gene24,25. Here, ZEB1 is linked to breast carcinoma.